Cardiovascular risk factors in type 2 diabetic patients in Mashhad City

Iranian Journal of Endocrinology and Metabolism

Volumn 12, Issue 1, 2010, Pages

  Bonakdaran, S ^a   Taghavi, M ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cardiovascular disease; Risk factors; Type 2 diabetes

Indexed keywords

CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; FEMALE; HUMAN; IRAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE;

EID: 77953509185     PISSN: 16834844     EISSN: 16835476     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Harati H, Hadaegh F, Saadat N, Azizi F. Population-based incidence of Type 2 diabetes and its associated risk factors: results from a six-year cohort study in Iran. BMC Public Health 2009; 9: 186.
2. Stirban AO, Tschoepe D. Cardiovascular complications in diabetes: targets and interventions. Diabetes Care 2008; 31 Suppl 2: S215-21.
3. Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol 2004; 44: 720-32.
4. Lu W, Resnick HE, Jablonski KA, Jones KL, Jain AK, Howard WJ, et al. Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart study. Diabetes Care 2003; 26: 16-23.
5. Khalangot M, Tronko M, Kravchenko V, Kulchinska J, Hu G. Body mass index and the risk of total and cardiovascular mortality among patients with type 2 diabetes: a large prospective study in Ukraine. Heart 2009; 95: 454-60.
6. Kalaitzidis R, Bakris G. Management of hypertension in patients with diabetes: the place of angiotensin-II receptor blockers. Diabetes Obes Metab 2009; 11: 757-69.
7. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, et al. (Diabetes control and complications trial/epidemiology of diabetes interventions and complications study research group). Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Eng J Med 2005; 353: 2643-53.
8. Yokoyama H, Oishi M, Kawai K, Sone H. Reduced GFR and microalbuminuria are independently associated with prevalent cardiovascular disease in Type 2 diabetes: JDDM study 16. Diabet Med 2008; 25: 1426-32.
9. Klausen KP, Parving HH, Scharling H, Jensen JS. Microalbuminuria and obesity: impact on cardiovascular disease and mortality. Clin Endocrinol (Oxf) 2009; 71: 40-5.
10. Grundy SM. Cardiovascular and metabolic risk factors: how can we improve outcomes in the high-risk patient? Am J Med 2007; 120 Suppl 1: S3-8.
11. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
12. Esteghamati A, Abbasi M, Rashidi A, Meysamie A, khalilzadeh O, Haghazali M, et al. Optimal waist circumference cut-off s for the diag nosis of metabo lic syndr ome in Iran ian adul ts: resu lts of the third nationa l surve y of risk facto rs of non-c ommu nicable disea ses (Su RFNCD -2007). Diabet Med 2009; 26: 745-6.
13. Berry C, Tardif JC, Bourassa MG. Coronary heart disease in patients with diabetes: part I: recent advances in prevention and noninvasive management. J Am Coll Cardiol 2007; 49: 631-42.
14. Safaei H, Amini M, Behrooz J, Teimori A. Cardiovascular risk factors in patients with newly diagnosed type 2 diabetes. Iranian Journal Of Endocrinology & Metabolism 2006; 29: 31-8. [Farsi]
15. Jurado J, Ybarra J, Solanas P, Caula J, Gich I, Pou JM, et al. Prevalence of cardiovascular disease and risk factors in a type 2 diabetic population of the North Catalonia diabetes study. J Am Acad Nurse Pract 2009; 21: 140-8.
16. Agarwal AK, Singla S, Singla S, Singla R, Lal A, Wardhan H, et al. Prevalence of coronary risk factors in type 2 diabetics without manifestations of overt coronary heart disease. J Assoc Physicians India 2009; 57: 135-42.
17. Romon I, Fosse S, Eschwège E, Simon D, Weill A, Varroud-Vial M, et al. Prevalence of macrovascular complications and cardiovascular risk factors in people treated for diabetes and living in France: the ENTRED study 2001. Diabetes Metab 2008; 34: 140-7.
18. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-72.
19. Pan CY, Ho LT, Soegondo S, Prodjosudjadi W, Suwanwalaikorn S, Lim SC, et al. Prevalence of albuminuria and cardiovascular risk profile in a referred cohort of patients with type 2 diabetes: an Asian perspective. Diabetes Technol Therapy 2008; 10: 397-403.
20. Azizi F, Saadat N, Salehi P, Emami H. Glucose intolerance and cardiovascular risk factors in Tehran urban population: "Tehran Lipid and Glucose Study". Iranian Journal of Endocrinology and Metabolism 2002; 12: 247-56. [Farsi]
21. Mohanty SA, Woolhandler S, Himmelstein DU, Bor DH. Diabetes and cardiovascular disease among Asian Indians in the United States. J Gen Intern Med 2005y; 20: 474-8.
22. Ye J, Rust G, Baltrus P, Daniels E. Cardiovascular risk factors among Asian Americans: results from a National Health Survey. Ann Epidemiol 2009; 19: 718-23.
23. [No authors listed] UK Prospective diabetes study (UKPDS). XI: biochemical risk factors in type 2 diabetic patients at diagnosis compared with age- matched normal subjects. Diabet Med 1994;11: 533-44.
24. [No authors listed] UK Prospective diabetes study.XII: Differences between asian.afro-caribbean and white caucasian type 2 diabetic patients at diagnosis of diabetes. UK Prospective study group. Diabet Med 1994; 11: 670-7.
25. Alsaraj F, McDermott JH, Cawood T, McAteer S, Ali M, Tormey W, et al. Prevalence of the metabolic syndrome in patients with diabetes mellitus. Ir J Med Sci. 2009; 178: 309-13.
26. Wong J, Molyneaux L, Constantino MI, Twigg SM, Yue DK. The metabolic syndrome in type 2 diabetes: when does it matter? Diabetes Obes Metab 2006; 8: 690-7.
27. Robles NR, Mena C, Velasco J, Angulo E, Garrote T, Garcia Gallego F. [Microalbuminuria-related cardiovascular risk in diabetic patients and hypertensive (non diabetic) population]. Med Clin (Barc) 2008; 130: 206-9.